~11 spots leftby Jan 2100

FES for Tremor Suppression

(Tremor Trial)

NS
Overseen ByNitin Sharma
Age: 18+
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Recruiting
Sponsor: North Carolina State University
Must not be taking: Neuromuscular junction drugs
Disqualifiers: Muscle weakness, Infection, Neuromuscular disorders, others
No Placebo Group

Trial Summary

What is the purpose of this trial?

This trial uses ultrasound imaging to study and understand hand tremors. It aims to help people with tremor disorders by accurately identifying involuntary muscle movements. The study includes both people with tremors and those without.

Do I need to stop my current medications for the trial?

The trial does not specify if you need to stop your current medications, but it excludes those using medications that affect the neuromuscular junction. It's best to discuss your specific medications with the trial coordinators.

What data supports the effectiveness of the treatment for tremor suppression using ultrasound imaging and electrical stimulation?

Research shows that ultrasound imaging can effectively visualize muscle activity and changes, which helps in monitoring and adjusting electrical stimulation for muscle strengthening and motor restoration. This suggests that combining ultrasound with electrical stimulation could be beneficial for controlling tremors by providing real-time feedback and personalized treatment adjustments.12345

Is functional electrical stimulation (FES) safe for humans?

Research on functional electrical stimulation (FES) for tremor suppression shows it can be used safely in humans, with studies indicating it effectively reduces tremors in conditions like essential tremor and Parkinson's disease. However, there are practical limitations, such as controlling only one pair of muscles at a time, which may restrict its use to certain types of tremors.678910

How does the FES treatment for tremor suppression differ from other treatments?

FES (Functional Electrical Stimulation) is unique because it uses electrical impulses to stimulate muscles, which can help suppress tremors by enabling controlled muscle movements. Unlike other treatments that might rely on medication or surgery, FES directly targets muscle activity and can be adjusted in real-time to manage muscle fatigue, making it a non-invasive and adaptable option for tremor management.1231112

Eligibility Criteria

This trial is for people aged 40-90 with Parkinson's Disease or tremor conditions, who have a rest tremor in their upper extremities. The tremor must be significant and re-emergent when holding a posture. Participants should not have other neuromuscular disorders, essential tremor, be on certain medications, or have muscle weakness.

Inclusion Criteria

I am between 40 and 90 years old.
I experience involuntary shaking in one or both of my arms.
Criterion: You must have a specific type of tremor that occurs when you hold an object, and it should start with a delay and grow in strength over a few seconds. The tremor should not be caused by anxiety, stress, cold temperature, or fatigue. We will give you time to relax before the test to help reduce these factors.
See 2 more

Exclusion Criteria

I have muscle weakness in my arm with tremors.
You have existing nerve or brain disorders.
I have been diagnosed with essential tremor by a specialist.
See 2 more

Trial Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants undergo ultrasound imaging and functional electrical stimulation to analyze and suppress tremors

3 years

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks

Treatment Details

Interventions

  • Analysis and Suppression of Tremor During Grasp Using Ultrasound Imaging and Electrical Stimulation (Procedure)
  • Electromyography (Behavioural Intervention)
  • Functional Electrical Stimulation (FES) (Behavioural Intervention)
  • Inertial Measurement Units (IMU) (Behavioural Intervention)
  • Ultrasound Imaging (Behavioural Intervention)
Trial OverviewThe study tests how well ultrasound imaging combined with electrical stimulation can identify and suppress hand tremors versus current methods like medication or surgery. It aims to differentiate between voluntary movements and involuntary tremors for better treatment strategies.
Participant Groups
2Treatment groups
Experimental Treatment
Group I: Tremor GroupExperimental Treatment4 Interventions
Individuals with either parkinson's disease or essential tremor will be recruited in this group
Group II: Able Body GroupExperimental Treatment4 Interventions
Individuals with no disorders will be recruited in this group

Find a Clinic Near You

Who Is Running the Clinical Trial?

North Carolina State University

Lead Sponsor

Trials
38
Recruited
50,000+

University of North Carolina, Chapel Hill

Collaborator

Trials
1,588
Recruited
4,364,000+

Findings from Research

Ultrasound myography (UMG) is a new technique that uses Doppler ultrasound to measure muscle movement velocity, providing a noninvasive way to assess muscle response to electrical stimulation.
Preliminary results show that UMG can effectively measure nerve conduction velocities in the forearm, with significant improvements in response times after warming the hand, suggesting its potential for clinical applications.
Ultrasound myography: application in nerve conduction velocity assessment and muscle cooling.Journรฉe, HL., de Jonge, AB.[2019]
A new ultrasound imaging protocol was developed to visualize muscle contractions from neuromuscular electrical stimulation (NMES) in stroke patients, demonstrating its potential for assessing muscle activation during therapy.
The study involved 35 patients and found that the motor threshold for NMES was 23.4 mA, with minimal correlation to body mass index or subcutaneous fat thickness, suggesting that ultrasound can help tailor NMES treatments to individual patient needs.
Using Portable Ultrasound to Monitor the Neuromuscular Reactivity to Low-Frequency Electrical Stimulation.PetraลŸ, A., Drฤƒgoi, RG., Pupazan, V., et al.[2021]
Ultrasound echogenicity has been shown to effectively indicate muscle fatigue during functional electrical stimulation (FES), demonstrating a strong linear relationship with fatigue levels in the tibialis anterior muscle during both isometric and dynamic movements.
This study, involving three human participants, suggests that using ultrasound as a fatigue indicator could improve the design of FES systems, allowing for better management of muscle fatigue during long-term tasks like walking.
Ultrasound Echogenicity-based Assessment of Muscle Fatigue During Functional Electrical Stimulation.Zhang, Q., Iyer, A., Lambeth, K., et al.[2022]

References

Ultrasound myography: application in nerve conduction velocity assessment and muscle cooling. [2019]
Using Portable Ultrasound to Monitor the Neuromuscular Reactivity to Low-Frequency Electrical Stimulation. [2021]
Ultrasound Echogenicity-based Assessment of Muscle Fatigue During Functional Electrical Stimulation. [2022]
Neuromuscular Ultrasound: A New Tool in Your Toolbox. [2019]
Skeletal muscle ultrasound. [2022]
Attenuation of pathological tremors by functional electrical stimulation. II: Clinical evaluation. [2019]
Augmented visual feedback counteracts the effects of surface muscular functional electrical stimulation on physiological tremor. [2021]
Attenuation of pathological tremors by functional electrical stimulation. I: Method. [2022]
Study on the elbow movement produced by functional electrical stimulation (FES). [2019]
Adaptive band-pass filter (ABPF) for tremor extraction from inertial sensor data. [2010]
Ultrasound Echogenicity as an Indicator of Muscle Fatigue during Functional Electrical Stimulation. [2022]
12.United Statespubmed.ncbi.nlm.nih.gov
Sonomyography Analysis on Thickness of Skeletal Muscle During Dynamic Contraction Induced by Neuromuscular Electrical Stimulation: A Pilot Study. [2017]